CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE1384.6033.25 (+2.46 %)
PREV CLOSE () 1351.35
OPEN PRICE () 1350.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3715
TODAY'S LOW / HIGH ()1350.00 1402.00
52 WK LOW / HIGH ()1140 1909.55
NSE1384.6031.9 (+2.36 %)
PREV CLOSE() 1352.70
OPEN PRICE () 1358.00
BID PRICE (QTY) 1384.60 (15)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 127185
TODAY'S LOW / HIGH() 1347.30 1402.50
52 WK LOW / HIGH ()1097.2 1910
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007

Management Info :

Amit Indubhushan Bakshi - Chairman Amit Indubhushan Bakshi - Managing Director

Registered Office :

Address : Shivarth Ambit, Plot No. 142/2,Ramdas Road, Off S B R,Near Swati Bungalows, Bodakdev,
Ahmedabad,
Gujarat-380054

Phone : 079 30451000 / 1001

Website : www.eris.co.in

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
24Feb Eris Lifesciences inks pact with Natco
Eris Lifesciences has entered into strategic partnership with Natco Phar..
24Feb Eris Lifesciences surges on inking pac
Eris Lifesciences is currently trading at Rs. 1382.95, up by 31.60 point..
24Feb Eris Lifesciences informs about press
Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligation..
20Feb Eris Lifesciences informs about earnin
Eris Lifesciences has informed that the transcript of the Analyst and In..
07Feb Eris Lifesciences informs about confer
Further to its letter dated February 06, 2026, intimating about the date..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit30.8999999999998773.899999999998
Gross Profit 38.8999999999998 1200.5
Operating Profit 1024.25220.6
Net Sales 3152.916977.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 5160.70 (1.79%)
M.Cap ( in Cr)
8566.44
Torrent Pharma (BSE)
 4398.70 (2.02%)
M.Cap ( in Cr)
148872.00
Natco Pharma (BSE)
 944.45 (5.74%)
M.Cap ( in Cr)
16916.03
Ipca Laboratories (BSE)
 1523.35 (3.14%)
M.Cap ( in Cr)
38648.03
Glenmark Pharma (BSE)
 2061.95 (1.18%)
M.Cap ( in Cr)
58188.40
Shareholding Pattern
PROMOTERS 54.85%
MUTUAL FUNDS/UTI 18.26%
NON-INSTITUTION 17.99%
FI/BANKS/INSURANCE 1.25%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX82225.92-1068.74 (-1.28%)
NIFTY25424.65-288.35 (-1.12%)
Dow Jones 49174.50370.44 (0.76%)
Nasdaq 22863.68236.41 (1.04%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI